DUBLIN–(BUSINESS WIRE)–The “Non-surgical Rhinoplasty Market Size, Share & Trends Analysis Report by Filler Type (HA Filler, CaHa Filler), by Application (Indentations of Dorsal Hump, Convex Nose, Minor Nasal Asymmetry), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global non-surgical rhinoplasty market size is expected to reach USD 1.3 billion by 2030 and is expected to register a CAGR of 8.1% from 2022 to 2030

Non-surgical rhinoplasty, also known as liquid rhinoplasty is a non-invasive cosmetic procedure used to alter the shape and define a person’s nose by using injectable fillers such as hyaluronic acid fillers. This method offers immediate results, no downtime, is less invasive, and is inexpensive. All these factors are expected to fuel the growth of the market.

Non-surgical rhinoplasty can be done in case a person has a dorsal bump, asymmetrical shape of the nose, dip in the nose bridge, improve/camouflage deformities, or treat mildly crooked nose. However, this procedure is only carried out to smooth out nasal imperfections and fix minor symmetry issues and cannot treat major nasal defects.

Injectable fillers like HA fillers and CaHa fillers are most commonly used in liquid Rhinoplasty procedures. However, as per Medical News Today, HA injectables are widely preferred and adopted by plastic surgeons and this is because these fillers are biocompatible, have a natural feel, provide a defined shape and complications can be reversed using hyaluronidase injection.

The market witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. However, it is expected to witness a recovery as the demand for non-invasive aesthetic treatments saw significant growth post-pandemic.

This is majorly due to increased virtual meets, increased disposable income, high social media impact, and desirability to improve aesthetic appearance. According to the American Society of Plastic Surgeons (ASPS), the pandemic led to an increase in the acceptance of cosmetic procedures

Non-surgical Rhinoplasty Market Report Highlights

• The HA filler segment is projected to dominate the market throughout the forecast period. It is the most preferred and highly adopted filler due to its biocompatibility and aesthetic benefits
• The minor nasal asymmetry application wheelchairs segment is projected to witness rapid growth over the forecast period as slight nasal misalignment due to genetics or minor injuries is expected to be prevalent in the global population
• The MedSpa end-use segment dominated the market owing to comprehensive services offered by such facilities, high accessibility, adoption of advanced products and technology as well as the availability of cost-effective treatments
• North America accounted for the highest revenue share in 2021 due to high awareness about non-invasive aesthetic treatment and the presence of major key players
• Asia Pacific is expected to grow at a CAGR of 8.8% over the forecast period, owing to the rising awareness and adoption of cosmetic treatments in Asian countries

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Non-Surgical Rhinoplasty Industry Outlook

Chapter 4 Non-Surgical Rhinoplasty Application Outlook

Chapter 5 Non-Surgical Rhinoplasty Filler Type Outlook

Chapter 6 Non-Surgical Rhinoplasty End-Use Outlook

Chapter 7 Non-Surgical Rhinoplasty Regional Outlook

Chapter 8 Competitive Landscape

• Skinovative of Gilbert-Medical Spa
• The London Cosmetic Clinic
• The Laser Skin Clinic
• Therapie Clinic
• Viva Skin Clinic.
• Toronto Cosmetic Clinic (Tcc)
• Piedmont Plastic Surgery & Dermatology
• Toronto Cosmetic Clinic (Tcc)
• Skin Vitality Medical Clinic
• Nova Aesthetic Clinic

For more information about this report visit https://www.researchandmarkets.com/r/9dkshu.